EGFR also functions in chemotherapeutic resistance and radiation tolerance in tumor cells, in which multiple downstream pathways of EGFR, including RAS-RAF-MAK-MAKP, PI3K/AKT, and STAT, are activated (31,33,35–38). Here, AKT1 is linked to neoplasm.